Additional file 3 of The impact of limited healthcare access among patients with light chain and transthyretin amyloidosis: real-world survey during COVID-19 lockdown period in France

Institutions

Université Paris-Est Créteil (FR)
Centre Hospitalier Universitaire de Grenoble (FR)
Centre Hospitalier Universitaire de Bordeaux (FR)
Centre Hospitalier Universitaire de Toulouse (FR)
Centre Hospitalier Universitaire de Besançon (FR)
Centre Hospitalier Universitaire de Montpellier (FR)
Normandie Université (FR)
Centre Hospitalier Universitaire de Poitiers (FR)
Groupe Hospitalier Mutualiste de Grenoble (FR)
CHU Dijon Bourgogne (FR)
Hôpital Pontchaillou (FR)
Hôpital Louis Pradel (FR)
Université de Rouen Normandie (FR)
Université Grenoble Alpes (FR)
Université de Caen Normandie (FR)

Publication Details

Journal: Figshare
Published: 2025-01-01
DOI: https://doi.org/10.6084/m9.figshare.29510606.v1
Primary Topic: Amyloidosis: Diagnosis, Treatment, Outcomes
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Additional file 3 of The impact of limited healthcare access among patients with light chain and transthyretin amyloidosis: real-world survey during COVID-19 lockdown period in France

Jan 1, 2025

Figshare

Amyloidosis: Diagnosis, Treatment, Outcomes

article

Additional file 3 of The impact of limited healthcare access among patients with light chain and transthyretin amyloidosis: real-world survey during COVID-19 lockdown period in France

January 1, 2025article en

Abstract

No abstract available for this paper.

Figshare

Université Paris-Est Créteil (FR), Centre Hospitalier Universitaire de Grenoble (FR), Centre Hospitalier Universitaire de Bordeaux (FR), Centre Hospitalier Universitaire de Toulouse (FR), Centre Hospitalier Universitaire de Besançon (FR), Centre Hospitalier Universitaire de Montpellier (FR), Normandie Université (FR), Centre Hospitalier Universitaire de Poitiers (FR), Groupe Hospitalier Mutualiste de Grenoble (FR), CHU Dijon Bourgogne (FR), Hôpital Pontchaillou (FR), Hôpital Louis Pradel (FR), Université de Rouen Normandie (FR), Université Grenoble Alpes (FR), Université de Caen Normandie (FR)

Openalex Percentile: Top 61%

Amyloidosis: Diagnosis, Treatment, Outcomes

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Additional file 3 of The impact of limited healthcare access among patients with light chain and transthyretin amyloidosis: real-world survey during COVID-19 lockdown period in France · Figshare (2025) | TGRS Research Map | TGRS